Edition:
United Kingdom

People: Glenmark Pharmaceuticals Ltd (GLEN.NS)

GLEN.NS on National Stock Exchange of India

559.00INR
24 May 2019
Change (% chg)

Rs-3.35 (-0.60%)
Prev Close
Rs562.35
Open
Rs564.20
Day's High
Rs567.00
Day's Low
Rs555.00
Volume
707,301
Avg. Vol
604,627
52-wk High
Rs711.90
52-wk Low
Rs505.50

Saldanha, Glenn 

Mr. Glenn Mario Saldanha serves as Executive Chairman of the Board, Chief Executive Officer, Managing Director of Glenmark Pharmaceuticals Ltd. Mr. Saldanha joined Glenmark in 1998 as Director and took over as Managing Director & CEO in 2000. He transformed Glenmark into a truly global organisation with revenue over a billion dollar. Under his leadership, Glenmark has evolved from an Indian branded generics business into a research-driven and innovation-led organisation. Mr. Saldanha’s vision is to discover, develop and take to market India's first innovative drug for the entire world.

Basic Compensation

Total Annual Compensation, INR 149,100,000
Restricted Stock Award, INR --
Long-Term Incentive Plans, INR --
All Other, INR 12,520,000
Fiscal Year Total, INR 161,620,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Glenn Saldanha

161,620,000

V. S. Mani

21,140,000

Harish Kuber

2,750,000

Cherylann Pinto

42,940,000

Rajesh Desai

1,200,000

Blanche Saldanha

400,000
As Of  31 Mar 2018